Metraipolis › archive › dc_4da8a7c87ac4

A conditional multi-signal validation framework for cancer immunotherapy: the adaptive anti-error biological system — Europe PMC PMID:42317319

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42317319
DOI
10.3389/fimmu.2026.1845119
License (as archived)
solo-consultazione
Archived
2026-10-10T00:54:25.632Z
SHA-256 of the archived text
12fa52c5bf586fc9200e912c106700bfdbc9706bb98059801f173d18077c5e86
Stable URL of this page
https://metraipolis.com/documento/dc_4da8a7c87ac4

How to cite

A conditional multi-signal validation framework for cancer immunotherapy: the adaptive anti-error biological system — Europe PMC PMID:42317319 — Europe PMC (en), https://europepmc.org/article/MED/42317319 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4da8a7c87ac4 (Metraipolis archive dc_4da8a7c87ac4, sha256 12fa52c5bf586fc9200e912c106700bfdbc9706bb98059801f173d18077c5e86)
BibTeX
@misc{dc4da8a7c87ac4,
  title = {A conditional multi-signal validation framework for cancer immunotherapy: the adaptive anti-error biological system — Europe PMC PMID:42317319},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42317319},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4da8a7c87ac4; sha256 12fa52c5bf586fc9200e912c106700bfdbc9706bb98059801f173d18077c5e86},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42317319. Agents can read the archived copy with the MCP tool read_document.